190 related articles for article (PubMed ID: 2450059)
1. Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins.
Jarasch ED; Nagle RB; Kaufmann M; Maurer C; Böcker WJ
Hum Pathol; 1988 Mar; 19(3):276-89. PubMed ID: 2450059
[TBL] [Abstract][Full Text] [Related]
2. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast.
Gould VE; Koukoulis GK; Jansson DS; Nagle RB; Franke WW; Moll R
Am J Pathol; 1990 Nov; 137(5):1143-55. PubMed ID: 1700618
[TBL] [Abstract][Full Text] [Related]
3. Histopathology of myoepithelial (basocellular) hyperplasias in adenosis and epitheliosis of the breast demonstrated by the reactivity of cytokeratins and S100 protein. An analysis of heterogenic cell proliferations in 90 cases of benign and malignant breast diseases.
Bässler R; Katzer B
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):435-42. PubMed ID: 1280883
[TBL] [Abstract][Full Text] [Related]
4. Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells.
Nagle RB; Böcker W; Davis JR; Heid HW; Kaufmann M; Lucas DO; Jarasch ED
J Histochem Cytochem; 1986 Jul; 34(7):869-81. PubMed ID: 2423579
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin intermediate filament expression in benign and malignant breast disease.
Heatley M; Maxwell P; Whiteside C; Toner P
J Clin Pathol; 1995 Jan; 48(1):26-32. PubMed ID: 7535804
[TBL] [Abstract][Full Text] [Related]
6. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast.
Joshi MG; Lee AK; Pedersen CA; Schnitt S; Camus MG; Hughes KS
Mod Pathol; 1996 Jan; 9(1):57-62. PubMed ID: 8821958
[TBL] [Abstract][Full Text] [Related]
7. Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue.
Reis-Filho JS; Steele D; Di Palma S; Jones RL; Savage K; James M; Milanezi F; Schmitt FC; Ashworth A
Mod Pathol; 2006 Feb; 19(2):307-19. PubMed ID: 16424897
[TBL] [Abstract][Full Text] [Related]
8. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study.
Gottlieb C; Raju U; Greenwald KA
Mod Pathol; 1990 Mar; 3(2):135-40. PubMed ID: 1691493
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.
Popnikolov NK; Cavone SM; Schultz PM; Garcia FU
Mod Pathol; 2005 Dec; 18(12):1535-41. PubMed ID: 16258511
[TBL] [Abstract][Full Text] [Related]
10. Intraductal carcinoma of the breast arising in sclerosing adenosis.
Ichihara S; Aoyama H
Pathol Int; 1994 Sep; 44(9):722-6. PubMed ID: 7804435
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of myoepithelial cells and basement membrane in normal, benign and malignant human breast lesions.
Tsubura A; Shikata N; Inui T; Morii S; Hatano T; Oikawa T; Matsuzawa A
Virchows Arch A Pathol Anat Histopathol; 1988; 413(2):133-9. PubMed ID: 2838950
[TBL] [Abstract][Full Text] [Related]
12. Tubular adenosis of the breast. A distinctive benign lesion mimicking invasive carcinoma.
Lee KC; Chan JK; Gwi E
Am J Surg Pathol; 1996 Jan; 20(1):46-54. PubMed ID: 8540608
[TBL] [Abstract][Full Text] [Related]
13. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
Raju UB; Lee MW; Zarbo RJ; Crissman JD
Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
[TBL] [Abstract][Full Text] [Related]
14. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues.
Sappino AP; Skalli O; Jackson B; Schürch W; Gabbiani G
Int J Cancer; 1988 May; 41(5):707-12. PubMed ID: 2835323
[TBL] [Abstract][Full Text] [Related]
15. Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue.
Dairkee SH; Puett L; Hackett AJ
J Natl Cancer Inst; 1988 Jul; 80(9):691-5. PubMed ID: 2453676
[TBL] [Abstract][Full Text] [Related]
16. Myoepithelial cells in solid variant of intraductal papillary carcinoma of the breast: a potential diagnostic pitfall and a proposal of an immunohistochemical panel in the differential diagnosis with intraductal papilloma with usual ductal hyperplasia.
Moritani S; Ichihara S; Kushima R; Okabe H; Bamba M; Kobayashi TK; Hattori T
Virchows Arch; 2007 May; 450(5):539-47. PubMed ID: 17377808
[TBL] [Abstract][Full Text] [Related]
17. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast.
Ichihara S; Fujimoto T; Hashimoto K; Moritani S; Hasegawa M; Yokoi T
Pathol Int; 2007 Mar; 57(3):126-32. PubMed ID: 17295644
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of S100 protein in benign and malignant conditions of the breast.
Egan MJ; Newman J; Crocker J; Collard M
Arch Pathol Lab Med; 1987 Jan; 111(1):28-31. PubMed ID: 3026280
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratins as markers of initial stages of squamous metaplasia in feline mammary carcinomas.
Ivanyi D; Minke JM; Hageman C; Groeneveld E; van Doornewaard G; Misdorp W
Am J Vet Res; 1993 Jul; 54(7):1095-102. PubMed ID: 7690208
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
